FDA Issues New Guidance for Pediatric Inflammatory Bowel Disease Drug Development
WASHINGTON, D.C. — The Food and Drug Administration (FDA) recently issued a draft guidance aimed at improving the clinical development of drugs to treat pediatric patients with inflammatory bowel disease …
FDA Issues New Guidance for Pediatric Inflammatory Bowel Disease Drug Development Read More